Form EFFECT CervoMed Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 10, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gildan CHRO Brooke Ferguson and Vitalant Chief People Officer Manny Ocasio Join the Mainstage Lineup for McLean & Company Signature 2026 in Las Vegas
- Recognized Today, Building What Comes Next
- Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist and Hematologist Mina Aleksan, MD
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
